Internal Medicine · Tucson, AZ
NPI
1023057700
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
7340 E Speedway Blvd, Suite 101
Tucson, AZ, 85710
Phone (520) 547-7047
Medicare paid, 2024
$252K
8,543 services
Medicare patients, 2024
272
Average age 73
Drug cost, 2024
$1.1M
11,160 prescriptions
Company payments, 2025
$440
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dung T Nguyen was code 99214 (office e&m - established), 1,140 times for 268 patients. In total Dung T Nguyen billed 8,543 services in 98 codes, and Medicare paid $252K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,140 | 268 | $88.20 | $101K |
| 36415 Venipuncture Blood Collection | Office | 666 | 244 | $8.63 | $5,746 |
| 80053 Clinical Chemistry | Office | 564 | 236 | $10.32 | $5,821 |
| 80061 Clinical Chemistry | Office | 501 | 233 | $13.08 | $6,553 |
| 85025 Blood Count | Office | 480 | 223 | $7.60 | $3,647 |
| 82306 Clinical Chemistry | Office | 383 | 179 | $29.01 | $11K |
| 83090 Clinical Chemistry | Office | 361 | 219 | $17.52 | $6,324 |
| 84443 Clinical Chemistry | Office | 339 | 205 | $16.46 | $5,580 |
| 86141 Clinical Chemistry | Office | 337 | 216 | $12.63 | $4,257 |
| 82043 Clinical Chemistry | Office | 318 | 160 | $5.66 | $1,800 |
| 82570 Clinical Chemistry | Office | 318 | 160 | $5.08 | $1,615 |
| 81001 Clinical Chemistry | Office | 298 | 174 | $3.09 | $922 |
| 83036 Blood Count | Office | 273 | 178 | $9.52 | $2,599 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 185 | 185 | $131.73 | $24K |
| 99497 Care Management/Coordination | Office | 177 | 176 | $74.15 | $13K |
By year: 2022 $251K for 7,890 services; 2023 $227K for 7,664 services; 2024 $252K for 8,543 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 666 | 244 | $8.63 | $5,746 |
| 80053 Clinical Chemistry | 564 | 236 | $10.32 | $5,821 |
| 80061 Clinical Chemistry | 501 | 233 | $13.08 | $6,553 |
| 85025 Blood Count | 480 | 223 | $7.60 | $3,647 |
| 82306 Clinical Chemistry | 383 | 179 | $29.01 | $11K |
| 83090 Clinical Chemistry | 361 | 219 | $17.52 | $6,324 |
| 84443 Clinical Chemistry | 339 | 205 | $16.46 | $5,580 |
| 86141 Clinical Chemistry | 337 | 216 | $12.63 | $4,257 |
| 82570 Clinical Chemistry | 318 | 160 | $5.08 | $1,615 |
| 82043 Clinical Chemistry | 318 | 160 | $5.66 | $1,800 |
Medicare prescription drug claims, 2024
In 2024, the drug Dung T Nguyen prescribed most often to Medicare patients was Rosuvastatin Calcium, with 693 prescriptions and refills. In total Dung T Nguyen wrote 11,160 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 693 | 1,981 | 210 | $5,940 |
| Levothyroxine Sodium Generic | 460 | 1,234 | 115 | $4,474 |
| Losartan Potassium Generic | 422 | 1,163 | 118 | $3,277 |
| Montelukast Sodium Generic | 386 | 997 | 109 | $4,570 |
| Amlodipine Besylate Generic | 382 | 1,052 | 99 | $2,205 |
| Atorvastatin Calcium Generic | 340 | 959 | 99 | $1,870 |
| Famotidine Generic | 308 | 777 | 95 | $7,474 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 292 | 292 | 185 | $2,372 |
| Metformin Hcl Generic | 271 | 755 | 80 | $1,888 |
| Lisinopril Generic | 259 | 725 | 71 | $1,680 |
| Metoprolol Succinate Generic | 213 | 568 | 59 | $2,169 |
| Felodipine Er Felodipine | 209 | 564 | 63 | $5,454 |
| Ezetimibe Generic | 198 | 538 | 57 | $3,799 |
| Gabapentin Generic | 172 | 488 | 82 | $4,666 |
| Pantoprazole Sodium Generic | 170 | 375 | 52 | $1,544 |
Brand drugs: 1,211 claims; generic drugs: 9,864 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dung T Nguyen $440 ($440 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $138.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $138 |
| Amgen Inc. AMGN | 3 | $50.79 |
| GlaxoSmithKline, LLC. GSK | 3 | $43.08 |
| Pfizer Inc. PFE | 2 | $34.12 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31.82 |
| Abbvie Inc. ABBV | 1 | $29.78 |
| Merck Sharp & Dohme LLC MRK | 1 | $22.64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20.55 |
| Sanofi Pasteur Inc. SNY | 1 | $19.96 |
| Exact Sciences Corporation EXAS | 1 | $17.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.